NASDAQ:ESTA - Establishment Labs Stock Price, Forecast & News

Establishment Labs trades on the NASDAQ under the ticker symbol "ESTA."

Establishment Labs Holdings Inc (NASDAQ:ESTA) issued its quarterly earnings results on Tuesday, November, 12th. The company reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.51) by $0.11. The business had revenue of $22.85 million for the quarter, compared to the consensus estimate of $20 million. Establishment Labs had a negative return on equity of 75.10% and a negative net margin of 52.76%. View Establishment Labs' Earnings History.

Establishment Labs is scheduled to release their next quarterly earnings announcement on Wednesday, March 18th 2020. View Earnings Estimates for Establishment Labs.

Establishment Labs updated its FY 2019 Pre-Market earnings guidance on Monday, November, 25th. The company provided EPS guidance of for the period. The company issued revenue guidance of $$86-87 million, compared to the consensus revenue estimate of $$85.39 million.

3 analysts have issued 12 month target prices for Establishment Labs' stock. Their forecasts range from $29.00 to $40.00. On average, they anticipate Establishment Labs' share price to reach $35.33 in the next twelve months. This suggests a possible upside of 30.7% from the stock's current price. View Analyst Price Targets for Establishment Labs.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Establishment Labs in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Establishment Labs.

News coverage about ESTA stock has trended negative recently, InfoTrie reports. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Establishment Labs earned a coverage optimism score of -2.3 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Establishment Labs.

Establishment Labs saw a drop in short interest in the month of December. As of December 31st, there was short interest totalling 690,500 shares, a drop of 9.9% from the December 15th total of 766,300 shares. Based on an average daily trading volume, of 100,700 shares, the days-to-cover ratio is presently 6.9 days. Currently, 4.4% of the company's stock are sold short. View Establishment Labs' Current Options Chain.

Some companies that are related to Establishment Labs include Avanos Medical (AVNS), Inogen (INGN), Sientra (SIEN), RTI Surgical (RTIX), Invacare (IVC), Lakeland Industries (LAKE), ConforMIS (CFMS), Histogenics (HSGX), COLLPLANT HOLDI/S (CLGN), Rewalk Robotics (RWLK), NanoVibronix (NAOV), Precision Therapeutics (POAI), Ocugen (OCGN), Bionik Laboratories (BNKL) and Allied Healthcare Products (AHPI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Establishment Labs investors own include Sientra (SIEN), AbbVie (ABBV), Enterprise Products Partners (EPD), Evolus (EOLS), Huntington Bancshares (HBAN), Methanex (MEOH), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM) and Conduent (CNDT).

(ESTA) raised $50 million in an initial public offering on Thursday, July 19th 2018. The company issued 3,100,000 shares at $15.00-$17.00 per share. Jefferies and Cowen served as the underwriters for the IPO and BTIG was co-manager.

Establishment Labs' stock is owned by a number of of institutional and retail investors. Top institutional investors include Calamos Advisors LLC (0.49%). Company insiders that own Establishment Labs stock include David L Bonvenuto, Jw Asset Management, Llc and Nicholas Sheridan Lewin. View Institutional Ownership Trends for Establishment Labs.

ESTA stock was bought by a variety of institutional investors in the last quarter, including Calamos Advisors LLC. Company insiders that have bought Establishment Labs stock in the last two years include David L Bonvenuto, Jw Asset Management, Llc and Nicholas Sheridan Lewin. View Insider Buying and Selling for Establishment Labs.

Shares of ESTA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ESTA stock can currently be purchased for approximately $27.03.

Establishment Labs has a market capitalization of $556.82 million and generates $61.21 million in revenue each year. The company earns $-21,100,000.00 in net income (profit) each year or ($1.12) on an earnings per share basis. Establishment Labs employs 505 workers across the globe.View Additional Information About Establishment Labs.

The official website for Establishment Labs is http://www.establishmentlabs.com/.

Establishment Labs' mailing address is Building B15 and 25 Coyol Free Zone, Alajuela G2, . The company can be reached via phone at 506 2434 2400 or via email at [email protected]